Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Genedrive COVID kit receives CE-IVD certification

Published 08/12/2021, 12:43
Updated 08/12/2021, 12:45
© Reuters

© Reuters

By Samuel Indyk

Investing.com – Shares in genedrive (LON:GDRG) shot higher before paring gains on Wednesday after the company announced that its rapid point of care Genedrive COV19-ID Kit had received CE-IVD certification under the European Communities Council Directive 98/79.

The kit is a diagnostic kit that can deliver positive results in under eight minutes and negative results in 17 minutes.

“This is an important milestone in the development of our new rapid molecular COVID19-ID test and we can now move forward with our commercial plans,” said genedrive CEO David Budd. “We have developed a very fast and easy to use Point of Care system that will allow immediacy and convenience in molecular testing, rather than waiting many hours or days for results from a central laboratory.”

The company reiterated that the product is being provided for review and evaluation to a range of potential commercial partners who have actively expressed interest in the product with regard to European opportunities.

Detection of Omicron

In the case of the new Omicron Variant of Concern, genedrive said there were approximately 650 Omicron genome sequences identified within the global reference database as of 7th December and the company’s kit was 100% inclusive in detection.

“The newest Variant of Concern highlights that COVID is an ongoing and long-term global health issue and our ability to manage it better can be aided by rapid detection to prevent ongoing transmissions, using innovative products like the new Genedrive COV19-ID kit,” Budd added.

At 12:50GMT shares in genedrive were trading higher by 2.0% at 48.00 pence per share.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.